Sharat Singh
Chief Tech/Sci/R&D Officer bei PROSPECT RESOURCES LIMITED
Profil
Sharat Singh is a professional with a doctorate degree from the Indian Institute of Science.
He currently holds the position of Head-Research at Prospect Resources Ltd.
and Biora Therapeutics, Inc. He previously held the position of Chief Scientific Officer at ACLARA Biosciences, Inc. from 1997 to 2005.
He also held the position of Chief Technology Officer-Oncology Division at Monogram Biosciences, Inc. Additionally, he was the Senior Vice President-Research & Development at WaferGen, Inc. and the Chief Scientific Officer & Vice President-Research at Prometheus Laboratories, Inc.
Aktive Positionen von Sharat Singh
| Unternehmen | Position | Beginn |
|---|---|---|
| PROSPECT RESOURCES LIMITED | Chief Tech/Sci/R&D Officer | - |
| BIORA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Sharat Singh
| Unternehmen | Position | Ende |
|---|---|---|
ACLARA Biosciences, Inc.
 ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | Chief Tech/Sci/R&D Officer | - |
WaferGen, Inc.
 WaferGen, Inc. BiotechnologyHealth Technology WaferGen, Inc. develops novel products for cell biology and genetic analysis. The firm focuses on the development systems for gene expression, genotyping and stem cell research for the life science and pharmaceutical industries. The company was founded by Alnoor Shivji, Victor Joseph and Amjad Huda and is headquartered in Fremont, CA. | Chief Tech/Sci/R&D Officer | - |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | - |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von Sharat Singh
| Indian Institute of Science | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PROSPECT RESOURCES LIMITED | Process Industries |
| BIORA THERAPEUTICS, INC. | Health Services |
| Private Unternehmen | 4 |
|---|---|
ACLARA Biosciences, Inc.
ACLARA Biosciences, Inc. Medical SpecialtiesHealth Technology ACLARA Biosciences, Inc. discovers, develops and markets innovative products to guide and improve treatment of serious viral, immunologic, and oncologic diseases. | Health Technology |
Monogram Biosciences, Inc.
Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Commercial Services |
WaferGen, Inc.
WaferGen, Inc. BiotechnologyHealth Technology WaferGen, Inc. develops novel products for cell biology and genetic analysis. The firm focuses on the development systems for gene expression, genotyping and stem cell research for the life science and pharmaceutical industries. The company was founded by Alnoor Shivji, Victor Joseph and Amjad Huda and is headquartered in Fremont, CA. | Health Technology |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
